Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Esper

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
American Journal of Clinical Oncology|February 1, 1997
Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostateK J Pienta, P S Esper, F Zwas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Urology|September 25, 1997
A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancerK J Pienta, B G Redman, R Bandekar, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 4, 2022
Learning the Language of Medical Device Innovation: A Longitudinal Interdisciplinary Elective for Medical StudentsLauren M Maloney, Mathew Hakimi, Thomas Hays, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
American Journal of Clinical Oncology|February 1, 1997
Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostateK J Pienta, P S Esper, F Zwas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Urology|September 25, 1997
A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancerK J Pienta, B G Redman, R Bandekar, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 4, 2022
Learning the Language of Medical Device Innovation: A Longitudinal Interdisciplinary Elective for Medical StudentsLauren M Maloney, Mathew Hakimi, Thomas Hays, et al.
Pageof 2